366
Views
26
CrossRef citations to date
0
Altmetric
In Vitro and Animal Studies

Potential fat-lowering and prebiotic effects of enzymatically treated okara in high-cholesterol-fed Wistar rats

, , &
Pages 828-833 | Received 14 Jan 2016, Accepted 07 Jun 2016, Published online: 26 Jun 2016
 

Abstract

This study evaluates the effect of the lipid profile on serum, liver and faeces, and the potential prebiotic effect of diets supplemented with enzymatically treated okara (okaraET) in high-cholesterol fed Wistar rats. Triglyceride levels were significantly reduced in the serum (p < 0.01) and liver (p < 0.01) of okaraET treated rats. Total lipids, triglycerides and bile acids were significantly higher (p < 0.001) in the faeces of rats fed the okaraET diet. The pH of faecal contents from treated okaraET rats was lower (p < 0.001), probably due to the significantly higher (p < 0.001) production of short-chain fatty acids (SCFA). OkaraET, therefore, reduced triglycerides in serum and liver, and increased the excretion of total lipids, triglycerides and bile acids, improving the lipid profile in rats fed with high-cholesterol diets. OkaraET fibre can improve intestinal transit by increasing faecal bulk. The decreased pH and increased SCFA production indicated that okaraET fibre fermentation occurred, suggesting a potential prebiotic effect.

Acknowledgements

All applicable international, national and/or institutional guidelines for the care and use of animals were followed. All procedures performed in studies involving animals were in accordance with the ethical standards of the institution or practise at which the studies were conducted.

Disclosure statement

All authors have no conflict of interest to report regarding the work presented in this manuscript.

Funding information

This research was supported by the Ministry of Science and Technology (Spain), Project AGL 2005-02447 and by Universidad Complutense de Madrid, Project GR3/14.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.